Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
New Portfolio - New Portfolio
Pero Blazevski
New PortfolioIndividual Investor
Ranked #271,976 out of 743,457 TipRanks' Investors
Success Rate
69 out of 132
profitable transactions
profitable transactions
Average Return
4.78%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 0.76%
6-Month Return▼ 1.15%
12-Month Return▲ 0.77%
YTD Return▼ 2.03%
Total Return▼ 29.62%
Best Trade
Bio
1
Performance
14.08%0-14.08%
▲ 9.22%
▲ 9.13%
▲ 3.00%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 8.92%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 6.42%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 4.92%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 7.17%
Mar 2024
▼ 12.40%
▼ 4.03%
▲ 3.73%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 4.42%
May 2024
▼ 2.25%
▲ 3.53%
▼ 2.52%
Jun 2024
▲ 9.22%▲ 9.13%▲ 3.00%
▲ 5.14%▲ 4.57%▲ 8.92%
▼ 1.87%▲ 1.59%▼ 6.42%
▲ 14.08%▲ 5.22%▲ 4.92%
▲ 5.05%▲ 3.27%▼ 7.17%
▼ 12.40%▼ 4.03%▲ 3.73%
▲ 11.46%▲ 5.06%▲ 4.42%
▼ 2.25%▲ 3.53%▼ 2.52%
Recent Activity
Weibo
3.03%
▼ 10.15%
1
Open
Apr 30, 2024
Eli Lilly & Co
3.03%
▲ 17.84%
1
Open
Apr 08, 2024
Novo Nordisk
3.03%
▲ 14.09%
1
Open
Apr 08, 2024
Viking Therapeutics
3.03%
▼ 33.62%
1
Open
Mar 27, 2024
XPeng, Inc. ADR
3.03%
▼ 18.93%
1
Open
Mar 20, 2024
Alibaba
3.03%
▲ 0.52%
3
Open
Feb 10, 2024
Bristol-Myers Squibb
3.03%
▼ 14.22%
1
Open
Feb 08, 2024
Tencent Holdings
3.03%
▲ 34.27%
3
Open
Jan 10, 2024
JD
3.03%
▲ 4.86%
1
Open
Jan 10, 2024
Argenx Se
3.03%
▲ 14.18%
1
Open
Dec 28, 2023
Li Auto
3.03%
▼ 44.62%
1
Open
Dec 26, 2023
Nvidia
3.03%
▲ 84.87%
3
Open
Dec 21, 2023
Legend Biotech
3.03%
▼ 23.35%
1
Open
Dec 21, 2023
Truth Social
―
▼ 71.87%
2
Close
Jul 20, 2023
Bioline RX Ltd Sponsored ADR
―
▼ 40.66%
2
Close
Jul 20, 2023
UR-Energy
―
▼ 7.87%
2
Close
Jul 20, 2023
Raytheon Technologies
―
▲ 39.41%
2
Close
Jul 20, 2023
China Online Education Group
―
▼ 14.48%
2
Close
Jul 20, 2023
Corbus Pharmaceuticals
―
▼ 82.85%
2
Close
Jul 20, 2023
Evofem Biosciences
―
▼ 99.96%
2
Close
Jul 20, 2023